Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer
Authors
Keywords
BRCA1, Triple-negative breast cancer, Mutation
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 137, Issue 1, Pages 119-125
Publisher
Springer Nature
Online
2012-11-29
DOI
10.1007/s10549-012-2348-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry
- (2012) Jing Zhang et al. BREAST CANCER RESEARCH AND TREATMENT
- Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations
- (2011) Soley Bayraktar et al. BREAST CANCER RESEARCH AND TREATMENT
- Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer
- (2011) Anne-Renee Hartman et al. CANCER
- Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer
- (2011) A. M. Gonzalez-Angulo et al. CLINICAL CANCER RESEARCH
- High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients
- (2011) James D. Fackenthal et al. INTERNATIONAL JOURNAL OF CANCER
- Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer
- (2011) D. G. Evans et al. JOURNAL OF MEDICAL GENETICS
- Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
- (2011) Karen A Gelmon et al. LANCET ONCOLOGY
- Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer
- (2011) Joyce O'Shaughnessy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Triple negative breast cancer: unmet medical needs
- (2010) Sumanta Kumar Pal et al. BREAST CANCER RESEARCH AND TREATMENT
- Expanding the Criteria forBRCAMutation Testing in Breast Cancer Survivors
- (2010) Janice S. Kwon et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- (2010) Andrew Tutt et al. LANCET
- The prevalence of BRCA1 mutations among young women with triple-negative breast cancer
- (2009) SR Young et al. BMC CANCER
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer
- (2008) Nancy U. Lin et al. CANCER
- Clinical and Pathologic Characteristics of Patients WithBRCA-Positive andBRCA-Negative Breast Cancer
- (2008) Deann P. Atchley et al. JOURNAL OF CLINICAL ONCOLOGY
- A Synthetic Lethal Therapeutic Approach: Poly(ADP) Ribose Polymerase Inhibitors for the Treatment of Cancers Deficient in DNA Double-Strand Break Repair
- (2008) Alan Ashworth JOURNAL OF CLINICAL ONCOLOGY
- Triple-negative/basal-like breast cancer: review
- (2008) Emad A. Rakha et al. PATHOLOGY
- BRCA1 regulates human mammary stem/progenitor cell fate
- (2008) S. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started